CRON.TO - Cronos Group Inc.

Toronto - Toronto Delayed Price. Currency in CAD
19.52
+0.06 (+0.31%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close19.46
Open19.51
Bid19.51 x 0
Ask19.54 x 0
Day's Range19.43 - 20.04
52 Week Range7.33 - 32.95
Volume472,159
Avg. Volume985,492
Market Cap6.521B
Beta (3Y Monthly)4.95
PE Ratio (TTM)35.11
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Aurora Cannabis Stock Falls on Bank of America Downgrade
    Market Realist3 days ago

    Aurora Cannabis Stock Falls on Bank of America Downgrade

    On Thursday, Bank of America downgraded Aurora Cannabis stock (ACB) to “neutral” from its previous “buy” rating. Here's why.

  • The Highest-Yielding Dividend Stock in Marijuana
    Motley Fool5 days ago

    The Highest-Yielding Dividend Stock in Marijuana

    This increasingly cannabis-focused company currently yields 6.5%.

  • 7 Reasons Aurora, Canopy, Cronos, and HEXO Are All At or Near 6-Month Lows
    Motley Fool5 days ago

    7 Reasons Aurora, Canopy, Cronos, and HEXO Are All At or Near 6-Month Lows

    The buzz is beginning to wear off for the most popular cannabis stocks.

  • 1 Top Cannabis Stock You Can Buy and Hold for the Next Decade
    Motley Fool6 days ago

    1 Top Cannabis Stock You Can Buy and Hold for the Next Decade

    This company can help you cash in on the global marijuana boom.

  • 10 Pure-Play Pot Stocks Forecast to Make Money in 2019
    Motley Fool6 days ago

    10 Pure-Play Pot Stocks Forecast to Make Money in 2019

    Despite supply and tax problems, some cannabis stocks are expected to make money this year.

  • Marijuana Stocks: Mapping Out Canada's Cannabis Invasion Of The U.S.
    Investor's Business Daily9 days ago

    Marijuana Stocks: Mapping Out Canada's Cannabis Invasion Of The U.S.

    Canadian cannabis companies have leapt onto U.S. stock markets, dazzling investors. Here's a rundown of industry facts and how to invest in marijuana stocks.

  • Cronos Group Could Break Key Moving Averages - Protect Long Positions
    TheStreet.com9 days ago

    Cronos Group Could Break Key Moving Averages - Protect Long Positions

    Cramer said he still sees Canopy Growth Corp. as the leader in the sector and also still recommended Cronos Group . In this daily bar chart of CRON, below, I don't want to focus on the rally into the February high but rather the decline from that high. After the March peak, CRON turned lower and broke below the rising 50-day average line which quickly turned bearish.

  • Why Cronos (CRON) Stock Still Has What It Takes
    SmarterAnalyst10 days ago

    Why Cronos (CRON) Stock Still Has What It Takes

    Cronos Group (CRON) has been one of the best performing large-cap stocks in the cannabis sector despite having a very small production capacity next to competitors of similar size. Cronos is expected to produce between 110,000 and 120,000 kg per year by 2020. Cronos has done a fantastic job with strategic partnerships that are sometimes more valuable than just production capacity alone, and this brings us to the age-old saying: quality over quantity.Cronos received a massive 2.4 billion-dollar (CAD) investment from the Altria late last year which sent the stock on a massive run from $13 to over $30 per share. This was big tobacco’s first large scale investment into the cannabis sector and many still believe that Cronos holds a massive advantage over their competitors due to the simple fact that they have Altria and its highly reputable brands backing up the company now.A lot of us that follow or invest in Cronos already know this, but it's always great to revisit past accomplishments to gauge if the company is on track and setting themselves up for the future. We all know that the market sometimes cares more about the future so what is Cronos up to right now that could have a positive impact on their share price and make them one stock worth buying today?A Strategic New Hire Could Open Huge DoorsOn Tuesday, July 9th Cronos announced it has hired Dr. Todd Abraham as Chief Innovation Officer. Dr. Abraham has worked for Nabisco, Pillsbury and more notably Mondelez in the past. Mondelez is a massive corporation that has a long list of highly successful consumer brands under their belt from Cadbury to Oreo’s. Dr. Abraham worked at Mondelez for 17 years prior to joining the Cronos and surely has deep ties in the company. This not only caused a jump in shares of Cronos but high speculation that Cronos plans to enter the consumer-packaged goods market in the future. This market is virtually untapped and could prove to be highly profitable with the right partnerships in place. Abraham will be working on research and development when it comes to consumer-packaged goods for Cronos.Cronos Wants To Be DifferentThis is a perfect example of how Cronos is using strategic hires and potential strategic partnerships to set themselves apart from their competition. Investors put too much emphasis on production capacity and not enough on valuable connections. This is where Cronos excels when it comes to its competition. They are also preparing to enter the CBD market in the United States as the market is set to explode and become a multi-billion dollar industry in just a few years. Their strategic partnership with Altria in America will more than likely give Cronos an advantage when sourcing hemp for CBD extraction. With this partnership in place, Cronos can use Altria's distribution network and presence in over 250,000 stores to move their product when they see fit. Moreover, Cronos has a global footprint that spans across five continents with plans to build out its proposed global network via strategic partnerships and joint ventures.Bottom lineWhen it comes to picking a cannabis company to invest in, there are so many options nowadays and we have seen many companies promise a lot and not deliver when the time comes. Like any growth industry, there are visionaries in the form of CEO’s promising that their companies are going to be industry leaders and make many millionaires rich. When we look at Cronos, we like the company for a few solid reasons. First off, Cronos is not showing as much emphasis on the Canadian recreational market as other companies, they are building a global network that we feel will be more lucrative in the future and will reward patient investors. Second, Cronos has already attracted one of the industry leaders in the tobacco business in the form of their massive 2.4 billion dollar investment, which is an accomplishment in itself, and paves the way for an immense distribution network that other competitors do not have when looking at the US market. Third, we like the fact that Cronos is making strategic hires and putting emphasis on markets like the consumer-packaged goods market, which will be a multi-billion-dollar opportunity if the US legalizes cannabis federally. These are some of the main reasons we think Cronos is worth looking at if you can stop comparing production capacity and look outside the box.To read more on the nitty gritty of what’s going on in the rising cannabis industry, click hereDisclosure: No position. Read more on CRON: * Don’t Buy The Hype: Cronos (CRON) Stock Is Still Risky * Bank of America Flips Over Cronos (CRON) Stock More recent articles from Smarter Analyst: * Curaleaf Helping to Put U.S. Cannabis Sector on the Map * Netflix’s (NFLX) Original Content Strategy Is Failing; The Stock Is Overvalued * Marijuana Stock KushCo (KSHB): Potential Catalysts Vs. Risks * Evercore Continues to Hold a Bullish View on Bank of America (BAC) Stock

  • Benzinga10 days ago

    Cronos Group Will Acquire GMP Compliant Fermentation, Manufacturing Facility

    Cronos Group (NASDAQ: CRON) (TSX:CRON) announced Thursday it entered into an agreement to acquire GMP compliant fermentation and manufacturing facility from Apotex Fermentation. The acquisition is expected to be completed during the third quarter, whereas Apotex Fermentation will continue to be in charge of a wind-down of the facility through Fall. Inside the facility are completely equipped laboratories, microbial fermentation production areas, and processing plants.

  • TheStreet.com10 days ago

    Cronos Rises After Announcing Acquisition of Winnipeg Fermentation Plant

    Cronos shares were rising Thursday after the cannabis company announced that it has entered into an agreement to purchase an 84,000-square-foot fermentation and manufacturing facility in Winnipeg, Canada. The facility will operate as "Cronos Fermentation" and include fully equipped laboratories covering microbiology, organic and analytical chemistry, quality control and method development. "This acquisition will provide the fermentation and manufacturing capabilities we need to capitalize on the work underway with Ginkgo once the milestones under that partnership are achieved," said Mike Gorenstein, CEO of Cronos Group.

  • Morningstar11 days ago

    Covering Cannabis

    For the United States, recreational cannabis and medicinal cannabis have penetrated just 8% and 21% of their estimated markets, leading to our expectation for 25% and 15% compound annual growth rates through 2030, respectively. For Canada, despite recent recreational legalization, cannabis has penetrated just 12% of our estimated market, setting the stage for a 20% CAGR through 2030. For the international market (which excludes Canada and the United States), we forecast market potential of nearly $43 billion and a 23% CAGR through 2030 as more and more countries recognize the benefits of medical cannabis.

  • How Technology Is About to Transform the $150B Cannabis Market
    Oilprice.com12 days ago

    How Technology Is About to Transform the $150B Cannabis Market

    An emerging data company has a unique solution to identify, manage and distribute cannabis products, but the potential of its technology could stretch beyond the booming marijuana markets

  • Benzinga12 days ago

    Cronos Group Names Todd Abraham As New Chief Innovation Officer

    Cronos Group (NASDAQ: CRON ) on Tuesday announced the appointment of Dr. Todd Abraham as the company's Chief Innovation Officer. Abraham "will be responsible for advancing Cronos Group’s research ...

  • Marijuana's "Big Four" Stocks Will Likely Lose Money in 2020
    Motley Fool12 days ago

    Marijuana's "Big Four" Stocks Will Likely Lose Money in 2020

    Rapid sales growth won't save these popular pot stocks from another year of red ink.

  • The 6 Best Marijuana Stocks in June
    Motley Fool13 days ago

    The 6 Best Marijuana Stocks in June

    A number of popular pot stocks regained their luster last month.

  • Investing in the Cannabis Industry
    Market Realist16 days ago

    Investing in the Cannabis Industry

    The cannabis industry has seen a boom over the last two years because of Canada's legalization of recreational use. We make sense of this growing sector.

  • Why Big Investors Eying $194 Billion Market Are High On Cannabis
    Investopedia18 days ago

    Why Big Investors Eying $194 Billion Market Are High On Cannabis

    Cannabis consumer: Investors want a piece of the action given the industry's explosive sales growth.

  • The 4 Must-Know Cannabis Vape Stocks
    Motley Fool18 days ago

    The 4 Must-Know Cannabis Vape Stocks

    Vaporizers and marijuana vape extracts could be a source of big-time growth in the years to come.

  • Why Marijuana Stock Cronos Group Jumped 13.5% in June
    Motley Fool18 days ago

    Why Marijuana Stock Cronos Group Jumped 13.5% in June

    This cannabis stock performed better than peers Canopy Growth, Aurora Cannabis, and Aphria last month.

  • A $1,000 Investment in Aurora, Canopy, Cronos, and HEXO at the Beginning of 2019 Is Worth This Much Today
    Motley Fool18 days ago

    A $1,000 Investment in Aurora, Canopy, Cronos, and HEXO at the Beginning of 2019 Is Worth This Much Today

    You'd have a lot of extra green in your pocket if you've owned any of these popular pot stocks since the year began.

  • OrganiGram Could Climb Higher, but You Need Discipline Before Buying
    TheStreet.com18 days ago

    OrganiGram Could Climb Higher, but You Need Discipline Before Buying

    One caller during Jim Cramer's fast paced Lightning Round on Mad Money asked about OrganiGram Holdings Inc. . OrganiGram Holdings is a licensed producer of medical marijuana so let's find a dispensary and check out the charts. In the daily bar chart of OGI, below, we can see an uptrend with a correction in October/December of 2018 and the start of another correction from late May. OGI is now trading below the declining 50-day moving average line but still above the cresting 200-day line.

  • Why Medicare for all could 'dramatically' increase access to medical marijuana
    Yahoo Finance20 days ago

    Why Medicare for all could 'dramatically' increase access to medical marijuana

    Medicare for all may not be just a Democratic talking point as the 2020 campaign kicks into high gear. It could also “dramatically” increase access to medical marijuana, according to Nicholas Vita, CEO of cannabis company Columbia Care.

  • The 10 Fastest-Growing Pot Stocks in 2020
    Motley Fool21 days ago

    The 10 Fastest-Growing Pot Stocks in 2020

    These cannabis stocks should see sales growth of at least 161% next year.

  • Canadian Marijuana Sales Hit an All-Time High in April (but Still Disappoint)
    Motley Fool22 days ago

    Canadian Marijuana Sales Hit an All-Time High in April (but Still Disappoint)

    The grass won't necessarily be greener for the weed industry anytime soon.

  • Motley Fool24 days ago

    The First Canadian Pot Stock to Generate Recurring Profits Will Be...

    Hint: It's probably not going to be one of the larger cannabis growers.